Overview
Efficacy and Safety of Moxonidine in Indian Patients
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Solvay PharmaceuticalsTreatments:
Moxonidine
Criteria
Inclusion Criteria:Hypertension
Exclusion Criteria:
Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant
hepatic disease, unstable angina